Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -93,908 | -56,473 | -77,211 | -73,561 | -60,941 |
| Depreciation Amortization | 47,261 | 21,536 | 96,029 | 71,724 | 44,569 |
| Income taxes - deferred | -10,083 | -704 | -68,378 | -32,735 | -29,681 |
| Accounts receivable | -31,030 | -51,690 | -54,274 | -95,884 | -77,416 |
| Other Working Capital | -101,023 | -78,219 | -49,420 | -113,334 | -100,734 |
| Other Operating Activity | 109,577 | 110,682 | 173,462 | 214,624 | 147,837 |
| Operating Cash Flow | $-79,206 | $-54,868 | $20,208 | $-29,166 | $-76,366 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,157 | -19,949 | 358,981 | 417,865 | -33,489 |
| PPE Investments | -61,387 | -28,756 | -144,620 | -102,541 | -52,682 |
| Purchase Sale Intangibles | -5,770 | -1,706 | 50,000 | 20,000 | 20,000 |
| Other Investing Activity | -6,578 | -1,774 | 49,990 | 19,990 | 19,159 |
| Investing Cash Flow | $-30,808 | $-50,479 | $264,351 | $335,314 | $-67,012 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,347 | -674 | -374,953 | N/A | N/A |
| Common Stock Issued | 19,013 | 5,798 | 67,488 | 55,643 | 44,926 |
| Other Financing Activity | -94,407 | -30,105 | -80,542 | -77,288 | -71,722 |
| Financing Cash Flow | $-76,741 | $-24,981 | $-388,007 | $-21,645 | $-26,796 |
| Exchange Rate Effect | 350 | 715 | -598 | -347 | -443 |
| Beginning Cash Position | 493,982 | 493,982 | 598,028 | 598,028 | 598,028 |
| End Cash Position | 307,577 | 364,369 | 493,982 | 882,184 | 427,411 |
| Net Cash Flow | $-186,405 | $-129,613 | $-104,046 | $284,156 | $-170,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,206 | -54,868 | 20,208 | -29,166 | -76,366 |
| Capital Expenditure | -61,387 | -28,756 | -144,620 | -102,541 | -52,682 |
| Free Cash Flow | -140,593 | -83,624 | -124,412 | -131,707 | -129,048 |